{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:07:00Z","timestamp":1779152820447,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T00:00:00Z","timestamp":1238025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T00:00:00Z","timestamp":1238025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1038\/leu.2009.52","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T10:49:07Z","timestamp":1238064547000},"page":"1446-1454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice"],"prefix":"10.1038","volume":"23","author":[{"given":"Y","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Michaels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,26]]},"reference":[{"key":"BFleu200952_CR1","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/nature03669","volume":"435","author":"F Michor","year":"2005","unstructured":"Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, Sawyers CL et al. Dynamics of chronic myeloid leukaemia. Nature 2005; 435: 1267\u20131270.","journal-title":"Nature"},{"key":"BFleu200952_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","volume":"109","author":"P Rousselot","year":"2007","unstructured":"Rousselot P, Huguet F, Rea D, Legros L, Cayuela JM, Maarek O et al. Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. Blood 2007; 109: 58\u201360.","journal-title":"Blood"},{"issue":"Part 5","key":"BFleu200952_CR3","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/BST0351347","volume":"35","author":"HG Jorgensen","year":"2007","unstructured":"Jorgensen HG, Holyoake TL . Characterization of cancer stem cells in chronic myeloid leukaemia. Biochem Soc Trans 2007; 35 (Part 5): 1347\u20131351.","journal-title":"Biochem Soc Trans"},{"key":"BFleu200952_CR4","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1182\/blood-2007-09-112573","volume":"111","author":"M Copland","year":"2008","unstructured":"Copland M, Pellicano F, Richmond L, Allan EK, Hamilton A, Lee FY et al. BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors. Blood 2008; 111: 2843\u20132853.","journal-title":"Blood"},{"key":"BFleu200952_CR5","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1182\/blood-2007-05-092056","volume":"111","author":"H Konig","year":"2008","unstructured":"Konig H, Holyoake TL, Bhatia R . Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src\/Abl kinase inhibitor SKI-606. Blood 2008; 111: 2329\u20132338.","journal-title":"Blood"},{"key":"BFleu200952_CR6","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/1097-0142(20010915)92:6<1591::AID-CNCR1485>3.0.CO;2-U","volume":"92","author":"HM Kantarjian","year":"2001","unstructured":"Kantarjian HM, Talpaz M, Santini V, Murgo A, Cheson B, O\u2019Brien SM . Homoharringtonine: history, current research, and future direction. Cancer 2001; 92: 1591\u20131605.","journal-title":"Cancer"},{"key":"BFleu200952_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/10245330410001714194","volume":"9","author":"CY Luo","year":"2004","unstructured":"Luo CY, Tang JY, Wang YP . Homoharringtonine: a new treatment option for myeloid leukemia. Hematology 2004; 9: 259\u2013270.","journal-title":"Hematology"},{"key":"BFleu200952_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/cncr.22398","volume":"109","author":"A Quintas-Cardama","year":"2007","unstructured":"Quintas-Cardama A, Kantarjian H, Garcia-Manero G, O\u2019Brien S, Faderl S, Estrov Z et al. Phase I\/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy. Cancer 2007; 109: 248\u2013255.","journal-title":"Cancer"},{"key":"BFleu200952_CR9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","volume":"189","author":"S Li","year":"1999","unstructured":"Li S, Ilaria Jr RL, Million RP, Daley GQ, Van Etten RA . The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 1999; 189: 1399\u20131412.","journal-title":"J Exp Med"},{"key":"BFleu200952_CR10","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood 1998; 92: 3780\u20133792.","journal-title":"Blood"},{"key":"BFleu200952_CR11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V83.1.43.43","volume":"83","author":"MH Finer","year":"1994","unstructured":"Finer MH, Dull TJ, Qin L, Farson D, Roberts MR . kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 1994; 83: 43\u201350.","journal-title":"Blood"},{"key":"BFleu200952_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1182\/blood.V97.1.4","volume":"97","author":"S Roumiantsev","year":"2001","unstructured":"Roumiantsev S, de Aos IE, Varticovski L, Ilaria RL, Van Etten RA . The src homology 2 domain of Bcr\/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase. Blood 2001; 97: 4\u201313.","journal-title":"Blood"},{"key":"BFleu200952_CR13","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1182\/blood-2004-11-4418","volume":"105","author":"CC Zhang","year":"2005","unstructured":"Zhang CC, Lodish HF . Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion. Blood 2005; 105: 4314\u20134320.","journal-title":"Blood"},{"key":"BFleu200952_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1534-5807(03)00018-2","volume":"4","author":"G de Haan","year":"2003","unstructured":"de Haan G, Weersing E, Dontje B, van Os R, Bystrykh LV, Vellenga E et al. In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Dev Cell 2003; 4: 241\u2013251.","journal-title":"Dev Cell"},{"key":"BFleu200952_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ng1343","volume":"36","author":"Y Hu","year":"2004","unstructured":"Hu Y, Liu Y, Pelletier S, Buchdunger E, Warmuth M, Fabbro D et al. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat Genet 2004; 36: 453\u2013461.","journal-title":"Nat Genet"},{"key":"BFleu200952_CR16","doi-asserted-by":"publisher","first-page":"16870","DOI":"10.1073\/pnas.0606509103","volume":"103","author":"Y Hu","year":"2006","unstructured":"Hu Y, Swerdlow S, Duffy TM, Weinmann R, Lee FY, Li S . Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. Proc Natl Acad Sci USA 2006; 103: 16870\u201316875.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu200952_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood-2006-10-054098","volume":"110","author":"C Peng","year":"2007","unstructured":"Peng C, Brain J, Hu Y, Goodrich A, Kong L, Grayzel D et al. Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells. Blood 2007; 110: 678\u2013685.","journal-title":"Blood"},{"key":"BFleu200952_CR18","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001; 344: 1038\u20131042.","journal-title":"N Engl J Med"},{"key":"BFleu200952_CR19","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa055229","volume":"354","author":"M Talpaz","year":"2006","unstructured":"Talpaz M, Shah NP, Kantarjian H, Donato N, Nicoll J, Paquette R et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med 2006; 354: 2531\u20132541.","journal-title":"N Engl J Med"},{"key":"BFleu200952_CR20","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1038\/sj.leu.2404772","volume":"21","author":"L Legros","year":"2007","unstructured":"Legros L, Hayette S, Nicolini FE, Raynaud S, Chabane K, Magaud JP et al. BCR-ABL(T315I) transcript disappearance in an imatinib-resistant CML patient treated with homoharringtonine: a new therapeutic challenge? Leukemia 2007; 21: 2204\u20132206.","journal-title":"Leukemia"},{"key":"BFleu200952_CR21","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","volume":"105","author":"KJ Aichberger","year":"2005","unstructured":"Aichberger KJ, Mayerhofer M, Krauth MT, Skvara H, Florian S, Sonneck K et al. Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. Blood 2005; 105: 3303\u20133311.","journal-title":"Blood"},{"key":"BFleu200952_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1532\/IJH97.06024","volume":"83","author":"HM Kantarjian","year":"2006","unstructured":"Kantarjian HM, Cortes J . New strategies in chronic myeloid leukemia. Int J Hematol 2006; 83: 289\u2013293.","journal-title":"Int J Hematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu200952.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200952","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200952.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:26:17Z","timestamp":1648729577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu200952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,26]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["BFleu200952"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.52","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,26]]},"assertion":[{"value":"10 October 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}